Nationwide Fund Advisors held its position in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 7,771 shares of the medical instruments supplier’s stock at the end of the 2nd quarter. Nationwide Fund Advisors owned approximately 0.21% of Utah Medical Products worth $563,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Strs Ohio raised its stake in Utah Medical Products by 8.0% in the second quarter. Strs Ohio now owns 2,700 shares of the medical instruments supplier’s stock valued at $195,000 after buying an additional 200 shares during the period. Everett Harris & Co. CA bought a new stake in Utah Medical Products in the second quarter valued at approximately $210,000. Prudential Financial Inc. bought a new stake in Utah Medical Products in the second quarter valued at approximately $233,000. Rice Hall James & Associates LLC raised its stake in Utah Medical Products by 1.1% in the second quarter. Rice Hall James & Associates LLC now owns 3,829 shares of the medical instruments supplier’s stock valued at $277,000 after buying an additional 40 shares during the period. Finally, Janney Montgomery Scott LLC raised its stake in Utah Medical Products by 9.3% in the second quarter. Janney Montgomery Scott LLC now owns 3,947 shares of the medical instruments supplier’s stock valued at $286,000 after buying an additional 335 shares during the period. Hedge funds and other institutional investors own 66.96% of the company’s stock.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 3rd. Investors of record on Friday, December 15th will be given a $0.27 dividend. The ex-dividend date of this dividend is Thursday, December 14th. This is a positive change from Utah Medical Products’s previous quarterly dividend of $0.27. This represents a $1.08 annualized dividend and a yield of Infinity. Utah Medical Products’s payout ratio is 28.80%.

Separately, BidaskClub lowered Utah Medical Products from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, July 25th.

ILLEGAL ACTIVITY WARNING: “Nationwide Fund Advisors Maintains Holdings in Utah Medical Products, Inc. (UTMD)” was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this report on another domain, it was illegally stolen and republished in violation of US & international trademark & copyright laws. The legal version of this report can be accessed at https://www.thecerbatgem.com/2017/11/03/nationwide-fund-advisors-maintains-holdings-in-utah-medical-products-inc-utmd.html.

Utah Medical Products Profile

Utah Medical Products, Inc (UTMD) is engaged in the business of producing medical devices that are disposable and for hospital use. The Company’s product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME, PATHFINDER PLUS, HOLMIUM LASER FIBRES, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN, and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts.

Institutional Ownership by Quarter for Utah Medical Products (NASDAQ:UTMD)

Receive News & Stock Ratings for Utah Medical Products Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products Inc. and related stocks with our FREE daily email newsletter.